Tuesday, September 29, 2020 7:35:04 AM
Aptose Biosciences, Inc. - Common Shares
Settlement Date Short Interest Percent Change Average Daily Share Volume Days to Cover
09/15/2020 2,409,092 24.71 1,207,956 1.99
08/31/2020 1,931,819 (5.72) 519,325 3.72
08/14/2020 2,049,128 (5.63) 801,051 2.56
07/31/2020 2,171,455 22.36 1,601,174 1.36
07/15/2020 1,774,702 9.91 515,028 3.45
06/30/2020 1,614,697 (13.31) 558,928 2.89
06/15/2020 1,862,679 2.17 519,790 3.58
05/29/2020 1,823,132 (7.80) 438,148 4.16
05/15/2020 1,977,460 84.14 880,866 2.24
04/30/2020 1,073,906 72.84 993,956 1.08
04/15/2020 621,323 29.58 616,511 1.01
03/31/2020 479,477 30.51 874,912 1.00
03/13/2020 367,399 (5.74) 923,990 1.00
02/28/2020 389,771 (5.16) 1,169,984 1.00
02/14/2020 410,957 13.76 877,492 1.00
01/31/2020 361,261 (27.03) 847,773 1.00
01/15/2020 495,065 59.70 1,337,976 1.00
12/31/2019 310,003 (32.19) 2,011,462 1.00
12/13/2019 457,186 78.44 1,898,992 1.00
11/29/2019 256,215 (18.44) 345,855 1.00
11/15/2019 314,157 (2.40) 306,949 1.02
10/31/2019 321,877 0.71 212,583 1.51
10/15/2019 319,607 (6.21) 377,304 1.00
09/30/2019 340,773 (3.74) 173,609 1.96
Recent APTO News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 10:00:16 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:51:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 11:06:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 10:45:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 10:26:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 10:15:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:56:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:52:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:50:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:44:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:39:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 09:33:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 09:02:15 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 01/26/2024 10:30:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 01:00:14 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/26/2024 05:15:19 AM
- Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)] • Edgar (US Regulatory) • 01/26/2024 02:44:21 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/20/2024 02:50:29 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/29/2023 09:10:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 11:30:13 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/11/2023 11:15:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/30/2023 10:28:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 10:00:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 01:15:11 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM